BIOPX (BIOPX) Stock Price & Analysis
BIOPX (BIOPX) fell 1.25% to USD 56.1 as of July 26, 2026 at 00:07 UTC, according to Nexqual real-time market data.
BIOPX last closed at USD 56.81; the session ranged USD 56.1–56.1 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 47.46–63.99 (NAS). Source: Nexqual, July 26, 2026 at 00:07 UTC.
Key Statistics (as of July 26, 2026 at 00:07 UTC)
| Price | USD 56.1 |
|---|---|
| Change | ▼ 1.25% (down) |
| Previous Close | USD 56.81 |
| Open | USD 56.1 |
| Day Range | USD 56.1 – 56.1 |
| 52-Week Range | USD 47.46 – 63.99 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (BIOPX)
Nexqual's technical model rates BIOPX "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 00:07 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 36.26 (neutral) |
| vs SMA50 | Below (USD 59.49) |
| MACD | -0.73 (negative) |
Financial Health Score (BIOPX)
Nexqual rates BIOPX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 00:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BPTRX | Baron Partners Fund | USD 240.39 | ▼ 2.03% |
| BFTHX | Baron Fifth Avenue Growth Fund | USD 67.55 | ▼ 2.96% |
| BGAFX | Baron Global Advantage Fd Retai | USD 53.31 | ▼ 2.27% |
| BFGFX | Baron Focused Growth Fund Retai | USD 56.16 | ▼ 0.92% |
| BARAX | Baron Asset Fund | USD 85.36 | ▲ 0.52% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 00:07 UTC. This page is informational and not investment advice.